COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
06 05 2021
Historique:
received: 25 01 2021
revised: 04 03 2021
accepted: 08 03 2021
pubmed: 31 3 2021
medline: 6 5 2021
entrez: 30 3 2021
Statut: ppublish

Résumé

Safe and effective vaccines against Coronavirus Disease 2019 (COVID-19) provide the best opportunity to control the pandemic. Having safe and efficacious vaccines available is only half the equation; people must also take them. We describe a study to identify COVID-19 vaccine attitudes, values and intentions immediately preceding authorization of COVID-19 vaccines in the US. A national panel survey was conducted to measure intent to receive COVID-19 vaccines as well as disease and vaccine attitudes, values and trust in local, state and federal public health authorities. Greater than 80% of respondents reported confidence they could adhere to COVID recommendations such as mask wearing, social distancing and hand washing. The majority of respondents (70%) reported believing that current drugs were somewhat or very good at treating COVID-19 infection. Vaccine intent fell into three groups: Intenders (50%), Wait and Learn (40%), and Unlikelys (10%). Intent to get vaccinated was substantially lower among African American (32%), and higher among men (56%), those over 60 years of age (61%), those with a Bachelor's degree or higher (63%), and Democrats (63%). The Wait and Learn group, compared to the Intenders, were less likely to report being diagnosed with a high risk condition for COVID-19, receiving an influenza vaccine in the past 12 months, discussing COVID-19 vaccine with their healthcare provider, perceiving COVID-19 as severe, considering a COVID-19 vaccine important to stop the spread of infection, and wering a mask usually or almost always. Only half of US adults intend to accept COVID-19 vaccines; most others (40%) are uncertain. Levels of immunity associated with community protection will not be achieved without reaching those who are currently uncertain. Characterizing COVID-19 vaccine attitudes and intentions and ascertaining values and trust in local, state, and federal public health authorities that impact vaccine decision-making are essential.

Identifiants

pubmed: 33781601
pii: S0264-410X(21)00315-7
doi: 10.1016/j.vaccine.2021.03.034
pmc: PMC7988387
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2698-2711

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
JAMA Netw Open. 2020 Dec 1;3(12):e2033324
pubmed: 33337490
Clin Infect Dis. 2021 Nov 16;73(10):1776-1783
pubmed: 33491049
JAMA. 2006 Oct 11;296(14):1757-63
pubmed: 17032989
Health Educ Behav. 2012 Apr;39(2):229-43
pubmed: 21984692
Pediatrics. 2013 Oct;132(4):624-30
pubmed: 24082000
JAMA. 2000 Dec 27;284(24):3145-50
pubmed: 11135778
Vaccine. 2021 Jan 29;39(5):825-829
pubmed: 33390295
Am J Public Health. 1997 Nov;87(11):1773-8
pubmed: 9366634
Health Aff (Millwood). 2021 Mar;40(3):419-425
pubmed: 33539178
PLoS One. 2021 Jan 7;16(1):e0244534
pubmed: 33411827
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
JAMA Netw Open. 2020 Oct 1;3(10):e2025594
pubmed: 33079199
Nat Rev Immunol. 2020 Oct;20(10):583-584
pubmed: 32908300
J Natl Med Assoc. 2005 Jul;97(7):951-6
pubmed: 16080664
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1657-1660
pubmed: 33382671
Br J Health Psychol. 2020 Nov;25(4):883-888
pubmed: 32519364

Auteurs

Daniel A Salmon (DA)

Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, United States; Department of International Health, Johns Hopkins Bloomberg School of Public Health, United States; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, United States. Electronic address: dsalmon1@jhu.edu.

Matthew Z Dudley (MZ)

Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, United States; Department of International Health, Johns Hopkins Bloomberg School of Public Health, United States.

Janesse Brewer (J)

Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, United States; Department of International Health, Johns Hopkins Bloomberg School of Public Health, United States.

Lilly Kan (L)

National Association of County and City Health Officials, United States.

Jennifer E Gerber (JE)

RTI International, United States.

Haley Budigan (H)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, United States.

Tina M Proveaux (TM)

Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, United States; Department of International Health, Johns Hopkins Bloomberg School of Public Health, United States.

Roger Bernier (R)

Aiken, SC 29803, United States(1).

Rajiv Rimal (R)

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, United States.

Benjamin Schwartz (B)

Fairfax County Health Department, VA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH